JP5671209B2 - マトリックスタンパク質の光活性化架橋結合による組織の結合および／または密閉 - Google Patents

マトリックスタンパク質の光活性化架橋結合による組織の結合および／または密閉 Download PDF

Info

Publication number
JP5671209B2
JP5671209B2 JP2008554565A JP2008554565A JP5671209B2 JP 5671209 B2 JP5671209 B2 JP 5671209B2 JP 2008554565 A JP2008554565 A JP 2008554565A JP 2008554565 A JP2008554565 A JP 2008554565A JP 5671209 B2 JP5671209 B2 JP 5671209B2
Authority
JP
Japan
Prior art keywords
tissue
fibrinogen
matrix protein
ligand complex
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008554565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526574A (ja
JP2009526574A5 (cg-RX-API-DMAC10.html
Inventor
ブラウンリー，アラン，ジョージ
エルビン，クリストファー，マルコルム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organisation
Original Assignee
Commonwealth Scientific and Industrial Research Organisation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006900770A external-priority patent/AU2006900770A0/en
Application filed by Commonwealth Scientific and Industrial Research Organisation filed Critical Commonwealth Scientific and Industrial Research Organisation
Publication of JP2009526574A publication Critical patent/JP2009526574A/ja
Publication of JP2009526574A5 publication Critical patent/JP2009526574A5/ja
Application granted granted Critical
Publication of JP5671209B2 publication Critical patent/JP5671209B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J189/00—Adhesives based on proteins; Adhesives based on derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
JP2008554565A 2006-02-14 2007-02-14 マトリックスタンパク質の光活性化架橋結合による組織の結合および／または密閉 Active JP5671209B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2006900770 2006-02-14
AU2006900770A AU2006900770A0 (en) 2006-02-14 Tissue adhesive using RU-catalysed cross-linking of fibrin or fibrinogen
PCT/AU2007/000156 WO2007092998A1 (en) 2006-02-14 2007-02-14 Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins

Publications (3)

Publication Number Publication Date
JP2009526574A JP2009526574A (ja) 2009-07-23
JP2009526574A5 JP2009526574A5 (cg-RX-API-DMAC10.html) 2010-01-14
JP5671209B2 true JP5671209B2 (ja) 2015-02-18

Family

ID=38371111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554565A Active JP5671209B2 (ja) 2006-02-14 2007-02-14 マトリックスタンパク質の光活性化架橋結合による組織の結合および／または密閉

Country Status (6)

Country Link
US (3) US9579415B2 (cg-RX-API-DMAC10.html)
EP (1) EP1986709B8 (cg-RX-API-DMAC10.html)
JP (1) JP5671209B2 (cg-RX-API-DMAC10.html)
AU (1) AU2007215382B2 (cg-RX-API-DMAC10.html)
CA (1) CA2640560C (cg-RX-API-DMAC10.html)
WO (1) WO2007092998A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2640560C (en) 2006-02-14 2017-07-11 Commonwealth Scientific And Industrial Research Organisation Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins
CA2696255C (en) 2007-08-14 2016-11-29 Commonwealth Scientific And Industrial Research Organisation Photoactivated crosslinking of a protein or peptide
WO2011133660A2 (en) * 2010-04-20 2011-10-27 Alfano Robert R Method for picosecond and femtosecond laser tissue welding
WO2014127198A1 (en) * 2013-02-15 2014-08-21 Joslin Diabetes Center Thymic regeneration
US20190022220A1 (en) * 2016-01-30 2019-01-24 The Board Of Trustees Of The Leland Stanford Junior University Light-activated anchoring of therapeutic factors to tissues
WO2018156807A1 (en) * 2017-02-22 2018-08-30 The General Hospital Corporation Methods of photochemical treatment for wound healing
US12558458B2 (en) 2017-05-18 2026-02-24 The Board Of Trustees Of The Leland Stanford Junior University Targeted in situ therapeutic delivery of secreted factors from stem cells for treatment of damaged tissue
US12599698B2 (en) 2021-10-28 2026-04-14 Kismet Technologies Inc. Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control
US12252629B2 (en) 2021-10-28 2025-03-18 Kismet Technologies Inc. Electronic device with self-disinfecting touch screen and method of manufacture
EP4676555A1 (en) * 2023-03-03 2026-01-14 CWAN Technologies Pty Ltd Molecular linkers

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474851A (en) * 1981-10-02 1984-10-02 The University Of Alabama In Birmingham Elastomeric composite material comprising a polypeptide
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
JPH06102628B2 (ja) * 1984-03-27 1994-12-14 イムノ・アクチエンゲゼルシャフト 組織接着材の製法
US5219895A (en) 1991-01-29 1993-06-15 Autogenesis Technologies, Inc. Collagen-based adhesives and sealants and methods of preparation and use thereof
US6967086B2 (en) * 1991-04-18 2005-11-22 Becton Dickinson And Company Method for determining the presence or absence of respiring cells on a three-dimensional scaffold
US5552452A (en) 1993-03-15 1996-09-03 Arch Development Corp. Organic tissue glue for closure of wounds
US5713891A (en) * 1995-06-02 1998-02-03 Children's Medical Center Corporation Modified solder for delivery of bioactive substances and methods of use thereof
WO1997042986A1 (en) 1996-05-14 1997-11-20 C. R. Bard, Inc. Methods and products for sealing a fluid leak in a tissue
US6613582B1 (en) * 1999-05-25 2003-09-02 Board Of Regents, The University Of Texas System Methods for rapid and efficient protein cross-linking
ES2383122T3 (es) * 1999-08-27 2012-06-18 Angiodevice International Gmbh Dispositivo de polímero biocompatible
CA2364939A1 (en) * 1999-12-22 2001-06-28 Surgical Sealants, Inc. Methods and compositions for sealing tissue leaks
US6607522B1 (en) * 2000-03-16 2003-08-19 General Hospital Corporation Methods for tissue welding using laser-activated protein solders
US20030032143A1 (en) * 2000-07-24 2003-02-13 Neff Thomas B. Collagen type I and type III compositions for use as an adhesive and sealant
US6607552B1 (en) * 2000-09-18 2003-08-19 Scimed Life Systems, Inc. Rolling socks
PL206194B1 (pl) * 2001-01-25 2010-07-30 Nycomed Pharma Asnycomed Pharma As Sposób wytwarzania zawiesiny cząstek fibrynogenu i trombiny, zawiesina zawierająca fibrynogen, trombinę i alkohol oraz sposób powlekania nośnika taką zawiesiną
US6703235B2 (en) * 2001-06-25 2004-03-09 Board Of Regents, The University Of Texas System Complex multicellular assemblies ex vivo
US6552172B2 (en) 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US20040101548A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Hemostatic wound dressing containing aldehyde-modified polysaccharide
WO2004010402A1 (es) 2002-07-17 2004-01-29 Fico Mirrors, Sa Dispositivo y metodo de vigilancia activa en un perimetro de seguridad de un vehiculo automovil
AU2003902474A0 (en) 2003-05-21 2003-06-05 Commonwealth Scientific And Industrial Research Organisation A bioelastomer i
CA2640560C (en) 2006-02-14 2017-07-11 Commonwealth Scientific And Industrial Research Organisation Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins

Also Published As

Publication number Publication date
US9669132B1 (en) 2017-06-06
WO2007092998A1 (en) 2007-08-23
EP1986709B8 (en) 2017-10-18
JP2009526574A (ja) 2009-07-23
AU2007215382A1 (en) 2007-08-23
US10441675B2 (en) 2019-10-15
US20090306707A1 (en) 2009-12-10
US20170151366A1 (en) 2017-06-01
EP1986709B1 (en) 2016-11-16
CA2640560C (en) 2017-07-11
US9579415B2 (en) 2017-02-28
EP1986709A1 (en) 2008-11-05
EP1986709A4 (en) 2012-06-06
CA2640560A1 (en) 2007-08-23
US20170232139A1 (en) 2017-08-17
AU2007215382B2 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
US20220040371A1 (en) Photoactivated crosslinking of a protein or peptide
US10441675B2 (en) Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins
Lauto et al. Adhesive biomaterials for tissue reconstruction
JP3446101B2 (ja) 組織治療用組成物
AU2004259027B2 (en) Tissue adhesive sealant
US20030008831A1 (en) Type III collagen compositions
JP2002524110A (ja) 血管密封材および創傷被覆材として用いるためのｉ型コラーゲンおよびｉｉｉ型コラーゲン止血性組成物
US20030032143A1 (en) Collagen type I and type III compositions for use as an adhesive and sealant
AU2004206150A1 (en) Hemostatic materials
JPH05502386A (ja) 色素で強化した接着剤をもつレーザーによる組織接合法
CN111465417B (zh) 止血用组合物以及包含上述止血用组合物的容器
JP2001511431A (ja) Ｉ型およびｉｉｉ型コラーゲン接着剤組成物
KR101786786B1 (ko) 개선된 피브린 밀봉 방법
Bhatia Traumatic injuries
Grimaldi et al. Biotechnological Approaches to Hemostasis and Molecular Mechanisms of Wound Healing
McNally-Heintzelman et al. Comparison of scaffold-enhanced albumin and n-butyl-cyanoacrylate adhesives for joining of tissue in a porcine model

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120829

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120905

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130129

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130426

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130528

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130910

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140310

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140422

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140709

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140716

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140818

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140825

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140919

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141022

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141125

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141219

R150 Certificate of patent or registration of utility model

Ref document number: 5671209

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250